These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 663899)

  • 1. Sequential effects of the thiol-oxidizing agent, diamide, on human platelets.
    Patscheke H; Wörner P
    Thromb Res; 1978 Apr; 12(4):609-18. PubMed ID: 663899
    [No Abstract]   [Full Text] [Related]  

  • 2. Localization of phosphatidylethanolamine in the plasma membrane of diamide-treated human blood platelets.
    Spangenberg P; Heller R; Wagner C; Till U
    Biomed Biochim Acta; 1985; 44(9):1335-41. PubMed ID: 4084279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diamide on aggregation, cytoskeletal proteins, and arachidonic acid metabolism in human platelets.
    Caruso D; Galli G; Till U; Spangenberg P; Lösche W; Paoletti R
    Thromb Res; 1984 Oct; 36(1):9-16. PubMed ID: 6438825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of reduced glutathione on platelet functions.
    Matsuda S; Ikeda Y; Aoki M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1979 Dec; 42(4):1324-31. PubMed ID: 542937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of platelet function by diamide corresponds to changes in phospholipid content of platelet cytoskeletons.
    Heller R; Spangenberg P; Till U
    Thromb Res; 1987 Apr; 46(2):385-90. PubMed ID: 3603431
    [No Abstract]   [Full Text] [Related]  

  • 7. Diamide induces reversible aggregation of human blood platelets.
    Lösche W; Burgess-Wilson M; Michel E; Heptinstall S; Till U
    Thromb Res; 1985 Dec; 40(6):869-74. PubMed ID: 4089841
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the GSH-disulfide status in the reversible and irreversible aggregation of human platelets.
    Bosia A; Spangenberg P; Lösche W; Arese P; Till U
    Thromb Res; 1983 Apr; 30(2):137-42. PubMed ID: 6868018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diamide mediated deaggregation of activated blood platelets is not caused by changes in adenine nucleotide pattern.
    Hofmann B; Hofmann J; Till U
    Biomed Biochim Acta; 1983; 42(5):K13-9. PubMed ID: 6418152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in morphology and protein pattern of human blood platelets during irreversible and diamide mediated reversible aggregation.
    Hofmann B; Danz R; Hofmann J; Pescarmona G; Bosia A; Meyer M; Lösche W; Till U
    Biomed Biochim Acta; 1983; 42(5):489-501. PubMed ID: 6418156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diamide and iodoacetamide on the expression of the glycoprotein IIb/IIIa complex on blood platelets.
    Johnston GI; Heptinstall S; Lösche W
    Biochem Biophys Res Commun; 1985 Mar; 127(3):822-7. PubMed ID: 2580519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modification of cytoskeletal proteins of human blood platelets by diamide.
    Spangenberg P; Heller R; Bosia A; Arese P; Till U
    Thromb Res; 1984 Dec; 36(6):609-18. PubMed ID: 6528312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of platelet tubulin in response to changes in free sulfhydryl groups.
    Steiner M
    Thromb Haemost; 1985 Apr; 53(2):176-9. PubMed ID: 4024027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochalasin B, the blood platelet release reaction and cyclic GMP.
    Haslam RJ; Davidson MM; McClenaghan MD
    Nature; 1975 Feb; 253(5491):455-7. PubMed ID: 163012
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of diamide (azodicarboxylic acid-bis-dimethylamide) on sulfhydryl group content, proteins, and the location of phosphatidylethanolamine in human blood platelets.
    Ostermann G; Spangenberg P; Meyer M; Herrmann FH; Till U
    Acta Haematol; 1982; 68(4):278-84. PubMed ID: 6217711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diamide and dibucaine on platelet glycoprotein Ib, actin-binding protein and cytoskeleton.
    Solum NO; Olsen TM
    Biochim Biophys Acta; 1985 Jul; 817(2):249-60. PubMed ID: 2990556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.
    Kirby EP
    Thromb Diath Haemorrh; 1975 Dec; 34(3):770-9. PubMed ID: 1239827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different requirements for intrinsic factor-Xa forming activity and platelet factor 3 activity and their relationship to platelet aggregation and secretion.
    Walsh PN; Camp E; Dende D
    Br J Haematol; 1978 Oct; 40(2):311-31. PubMed ID: 708650
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.